Sectors
EBS
Emergent BioSolutions Inc.
4.52
9 x 4.50
1 x 4.51
bid
ask
+
0.05
1.12%
09:38 AM
timesize
| Ytd | -63.43% | |
| 1y | -44.61% |
4.46
day range
4.52
4.36
52 week range
14.06
| Open | 4.47 | Prev Close | 4.47 | Low | 4.46 | High | 4.52 | Mkt Cap | 232.96M |
| Vol | 58.61K | Avg Vol | 955.07K | EPS | 1.44 | P/E | 3.14 | Forward P/E | 2.73 |
| Beta | 2.35 | Short Ratio | 4.54 | Inst. Own | 60.02% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-30 | 50-d Avg | 7.77 | 200-d Avg | 9.51 | 1yr Est | 12.00 |
| Income Statement | |||
| Total Revenue | 234.30M | ||
| Revenues (USD) | 234.30M | ||
| Cost of Revenue | 97.10M | ||
| Gross Profit | 137.20M | ||
| Operating Expenses | 262.30M | ||
| Research and Development Expense | 9.20M | ||
| Selling, General and Administrative Expense | 44.60M | ||
| Operating Income | -125.10M | ||
| Interest Expense | 10.00M | ||
| Income Tax Expense | 13.90M | ||
| Net Income | -180.20M | ||
| Net Income Common Stock | -180.20M | ||
| Net Income Common Stock (USD) | -180.20M | ||
| Consolidated Income | -180.20M | ||
| Earnings per Basic Share | -3.49 | ||
| Earnings per Basic Share (USD) | -3.49 | ||
| Earnings per Diluted Share | -3.49 | ||
| Earning Before Interest & Taxes (EBIT) | -156.30M | ||
| Earning Before Interest & Taxes (USD) | -156.30M | ||
| Weighted Average Shares | 51.60M | ||
| Weighted Average Shares Diluted | 51.60M | ||
| Balance Sheet | |||
| Cash and Equivalents | 140.90M | ||
| Cash and Equivalents (USD) | 140.90M | ||
| Trade and Non-Trade Receivables | 190.00M | ||
| Current Assets | 666.00M | ||
| Property, Plant & Equipment Net | 178.00M | ||
| Total Assets | 1.12B | ||
| Total Debt | 581.80M | ||
| Current Liabilities | 122.80M | ||
| Debt Non-Current | 581.80M | ||
| Total Liabilities | 775.40M | ||
| Accumulated Retained Earnings (Deficit) | -333.20M | ||
| Accumulated Other Comprehensive Income | -6.80M | ||
| Shareholders Equity | 341.40M | ||
| Shareholders Equity (USD) | 341.40M | ||
| Assets Non-Current | 450.80M | ||
| Total Debt (USD) | 581.80M | ||
| Deferred Revenue | 15.00M | ||
| Goodwill and Intangible Assets | 261.80M | ||
| Inventory | 303.60M | ||
| Liabilities Non-Current | 652.60M | ||
| Trade and Non-Trade Payables | 50.20M | ||
| Tax Liabilities | 39.80M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 24.00M | ||
| Net Cash Flow from Financing | -24.40M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -20.60M | ||
| Capital Expenditure | -1.90M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -50.40M | ||
| Issuance (Purchase) of Equity Shares | -8.00M | ||
| Issuance (Repayment) of Debt Securities | -4.50M | ||
| Net Cash Flow from Investing | -52.30M | ||
| Net Cash Flow from Operations | 56.10M | ||
| Share Based Compensation | 6.90M | ||